Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States.

Diğer sürümleri göster (2)

The heptavalent pneumococcal conjugate vaccine (PCV7) was introduced in the United States (US) in 2000 and has significantly reduced invasive pneumococcal disease; however, the incidence of nonvaccine serotype invasive disease, particularly due to serotype 19A, has increased. The serotype 19A increa...

Detaylı Bibliyografya
Asıl Yazarlar:	Brueggemann, A, Pai, R, Crook, D, Beall, B
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	2007

Benzer Materyaller

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
Yazar:: Brueggemann, A, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Vaccine escape recombinants emerge after pneumococcal vaccination in the United States
Yazar:: Brueggemann, AB, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event.
Yazar:: Golubchik, T, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Pneumococcal genome sequencing tracks a vaccine escape variant formed through a multi-fragment recombination event
Yazar:: Golubchik, T, ve diğerleri
Baskı/Yayın Bilgisi: (2012)

Evidence for soft selective sweeps in the evolution of pneumococcal multidrug resistance and vaccine escape.
Yazar:: Croucher, N, ve diğerleri
Baskı/Yayın Bilgisi: (2014)

Impact of pneumococcal conjugate vaccines on hospitalizations for pneumonia in the United States
Yazar:: Andrew D. Wiese, ve diğerleri
Baskı/Yayın Bilgisi: (2019-04-01)

Molecular epidemiology of paediatric invasive pneumococcal disease in southern Spain after the introduction of heptavalent pneumococcal conjugate vaccine.
Yazar:: Obando, I, ve diğerleri
Baskı/Yayın Bilgisi: (2007)

An assessment of the screening method to evaluate vaccine effectiveness: the case of 7-valent pneumococcal conjugate vaccine in the United States.
Yazar:: Adam L Cohen, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Pneumococcal Vaccination in the United States: Current Recommendations and Strategies to Improve Vaccination Coverage
Yazar:: Cynthia G Whitney
Baskı/Yayın Bilgisi: (1999-01-01)

State of pneumococcal vaccine immunity
Yazar:: Mustafa Akkoyunlu
Baskı/Yayın Bilgisi: (2024-12-01)

Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
Yazar:: Sandra S. Richter, ve diğerleri
Baskı/Yayın Bilgisi: (2013-07-01)

Pneumococcal Vaccines
Yazar:: D. E. Briles, ve diğerleri
Baskı/Yayın Bilgisi: (2019-12-01)

Invasive pneumococcal disease: epidemiology in children and adults prior to implementation of the conjugate vaccine in the Oxfordshire region, England.
Yazar:: Foster, D, ve diğerleri
Baskı/Yayın Bilgisi: (2008)

An evaluation of emerging vaccines for childhood pneumococcal pneumonia
Yazar:: Zhang Jian Shayne F, ve diğerleri
Baskı/Yayın Bilgisi: (2011-04-01)

Knowledge, attitudes, and perceptions towards pneumococcal vaccines among adults in the United States
Yazar:: Salini Mohanty, ve diğerleri
Baskı/Yayın Bilgisi: (2025-12-01)

Preferences and attitudes of healthcare providers towards pneumococcal vaccines for adults in the United States
Yazar:: Salini Mohanty, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Emerging vaccine strategies against the incessant pneumococcal disease
Yazar:: Jeremy A. Duke, ve diğerleri
Baskı/Yayın Bilgisi: (2023-08-01)

Changes in the pneumococcal vaccine serotypes in adult noninvasive pneumonia after the introduction of pneumococcal conjugate vaccination for children
Yazar:: Hiroaki Takeda, ve diğerleri
Baskı/Yayın Bilgisi: (2019-01-01)

Missed opportunities for pneumococcal vaccinations in high-risk and older adults in the United States
Yazar:: Omotola Olasupo, ve diğerleri
Baskı/Yayın Bilgisi: (2020-01-01)

Invasive pneumococcal disease in England and Wales: vaccination implications.
Yazar:: Sleeman, K, ve diğerleri
Baskı/Yayın Bilgisi: (2001)

Pneumococcal Conjugate Vaccination Followed by Pneumococcal Polysaccharide Vaccination in Lung Transplant Candidates and Recipients
Yazar:: Thijs W. Hoffman, MD, ve diğerleri
Baskı/Yayın Bilgisi: (2020-06-01)

No long-term evidence of hyporesponsiveness after use of pneumococcal conjugate vaccine in children previously immunized with pneumococcal polysaccharide vaccine
Yazar:: Licciardi, P, ve diğerleri
Baskı/Yayın Bilgisi: (2016)

Generalized granuloma annulare after pneumococcal vaccination,
Yazar:: Miguel Fernando García-Gil, ve diğerleri
Baskı/Yayın Bilgisi: (2021-03-01)

Pneumococcal vaccination in developing countries.
Yazar:: Levine, O, ve diğerleri
Baskı/Yayın Bilgisi: (2006)

Understanding healthcare providers’ preferred attributes of pediatric pneumococcal conjugate vaccines in the United States
Yazar:: Salini Mohanty, ve diğerleri
Baskı/Yayın Bilgisi: (2024-12-01)

Variation of pneumococcal Pilus-1 expression results in vaccine escape during Experimental Otitis Media [EOM].
Yazar:: Marisol Figueira, ve diğerleri
Baskı/Yayın Bilgisi: (2014-01-01)

Pneumococcal vaccines in China
Yazar:: Shanshan Wang, ve diğerleri
Baskı/Yayın Bilgisi: (2025-12-01)

Recent Topics of Pneumococcal Vaccination: Indication of Pneumococcal Vaccine for Individuals at a Risk of Pneumococcal Disease in Adults
Yazar:: Nobuhiro Asai, ve diğerleri
Baskı/Yayın Bilgisi: (2021-11-01)

A dynamic model of pneumococcal infection in the United States: implications for prevention through vaccination.
Yazar:: Van Effelterre, T, ve diğerleri
Baskı/Yayın Bilgisi: (2010)

Preferences for Adult Pneumococcal Vaccine Recommendations Among United States Health Care Providers
Yazar:: Patricia Sacco, ve diğerleri
Baskı/Yayın Bilgisi: (2019-09-01)

Vaccination of Icelandic children with the 10-valent pneumococcal vaccine leads to a significant herd effect among adults in Iceland
Yazar:: Quirk, S, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Pneumococcal responses are similar in Papua New Guinean children aged 3-5 years vaccinated in infancy with pneumococcal polysaccharide vaccine with or without prior pneumococcal conjugate vaccine, or without pneumococcal vaccination.
Yazar:: Anita H J van den Biggelaar, ve diğerleri
Baskı/Yayın Bilgisi: (2017-01-01)

Decrease in pneumococcal co-colonization following vaccination with the seven-valent pneumococcal conjugate vaccine.
Yazar:: Carina Valente, ve diğerleri
Baskı/Yayın Bilgisi: (2012-01-01)

Invasive Pneumococcal Disease after Routine Pneumococcal Conjugate Vaccination in Children, England and Wales
Yazar:: Shamez N. Ladhani, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
Yazar:: Brueggemann, A, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Conjugation Mechanism for Pneumococcal Glycoconjugate Vaccines: Classic and Emerging Methods
Yazar:: Victor Morais, ve diğerleri
Baskı/Yayın Bilgisi: (2022-12-01)

PNEUMOCOCCAL INFECTION VACCINAL PREVENTION EFFICACY IN CHILDREN USING PNEUMOCOCCAL CONJUGATED 7-VALENT VACCINE
Yazar:: N. L. Chernaya, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

State of the globe: Effect of pneumococcal conjugate vaccines on nonvaccine-type invasive pneumococcal disease
Yazar:: Sunil Kumar Raina
Baskı/Yayın Bilgisi: (2019-01-01)

Population genetic structure of Streptococcus pneumoniae in Kilifi, Kenya, prior to the introduction of pneumococcal conjugate vaccine
Yazar:: Brueggemann, AB, ve diğerleri
Baskı/Yayın Bilgisi: (2013)

Pneumococcal Nasopharyngeal Carriage in Young Healthy Children After Pneumococcal Conjugate Vaccine in Turkey
Yazar:: Ahmet Arvas, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)